Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

April 2026; Volume 46,Issue 4

Reviews

  • Open Access
    Gene Therapy for Malignant Tumors: Focused on Immunostimulatory Oncolytic Coxsackievirus A11 (CVA11)
    HISANOBU OGATA, HARUKI NAGANO, YUTAKA FUJIOKA, ATSUSHI MATSUZAWA, ATSUSHI ENOMOTO, TOSHIHISA TSURUTA, TOSHIHIKO OKAZAKI, SHINTARO KAWANO, HIDEYA ONISHI, KENOKI OHUCHIDA, HIROAKI NIIRO and KENZABURO TANI
    Anticancer Research April 2026, 46 (4) 1757-1761; DOI: https://doi.org/10.21873/anticanres.18071
  • Open Access
    The Impact of Exercise and Diet on Ovarian Cancer Mortality
    JOHN P. MICHA, RANDY BOHART and BRAM H. GOLDSTEIN
    Anticancer Research April 2026, 46 (4) 1763-1768; DOI: https://doi.org/10.21873/anticanres.18072

Experimental Studies

  • Open Access
    P53-armed Oncolytic Adenovirus Enhances the Efficacy of PD-1 Blockade in Neuroblastoma by Inducing Immunogenic Cell Death
    MORIMICHI TANI, HIROSHI TAZAWA, TERUTAKA TANIMOTO, HIROSHI NOUSO, HINAKO WATANABE, TAKANORI OYAMA, YASUO URATA, SHUNSUKE KAGAWA, TAKUO NODA, SHINJI KURODA and TOSHIYOSHI FUJIWARA
    Anticancer Research April 2026, 46 (4) 1769-1784; DOI: https://doi.org/10.21873/anticanres.18073
  • Open Access
    Advanced Reliability of Radiomic Features in Ex Vivo HypersightTM-CBCT Imaging by iCBCT-Acuros Reconstruction
    VICTOR SIEFERT, FLORIAN HAAG, ALICIA S. BICU, RALF SCHMIDT, MARVIN WILLAM, MIRIAM ECKL, FLORIAN STIELER, MICHAEL EHMANN, DANIEL BUERGY, JENS FLECKENSTEIN, STEFAN O. SCHOENBERG, FRANK A. GIORDANO, JUDIT BODA-HEGGEMANN, MATTHIAS F. FROELICH and CONSTANTIN DREHER
    Anticancer Research April 2026, 46 (4) 1785-1798; DOI: https://doi.org/10.21873/anticanres.18074
  • Open Access
    BIT1 as an Effector of EGFR-TKI-induced Apoptosis via TLE1 Inhibition in Lung Adenocarcinoma Cells
    MA CARMELA DELA CRUZ, XIN YAO, ALAJAH NEALY, JAMES BAILEY, MICAH NALLS, PAUL MARK MEDINA, RENWEI CHEN and HECTOR BILIRAN
    Anticancer Research April 2026, 46 (4) 1799-1818; DOI: https://doi.org/10.21873/anticanres.18075
  • Open Access
    Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents
    KUMIKO MIYASHITA, KIMIHIRO YAMASHITA, MAKOTO MIYOSHI, TAKAAKI NISHIYAMA, YUKI ISE, SHUN OHSAKA, KAZUYA SHIMIZU, NORIYUKI NISHIMURA and YUICHI HORI
    Anticancer Research April 2026, 46 (4) 1819-1831; DOI: https://doi.org/10.21873/anticanres.18076
  • Open Access
    Unveiling the Molecular Blueprint of Spinach Induced Anti-proliferation and Pro-apoptosis in Cervical Cancer
    JACOB M. PARKER, LOGAN R. WILLIAMS, NATHAN A. HAINES, TRENTON G. MAYBERRY, BRAYDON C. COWAN, AUSTIN J. MAHER, AUSTIN J. MARRAH, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research April 2026, 46 (4) 1833-1841; DOI: https://doi.org/10.21873/anticanres.18077
  • Open Access
    Cyclin-dependent Kinase 5 Promotes Myc Stabilization Through Inhibitory Phosphorylation of GSK-3β in Ewing Sarcoma
    MASANORI KAWANO, YUTA KUBOTA, ICHIRO ITONAGA, NOBUHIRO KAKU and KAZUHIRO TANAKA
    Anticancer Research April 2026, 46 (4) 1843-1859; DOI: https://doi.org/10.21873/anticanres.18078
  • Open Access
    Insights From Matrix Metalloproteinase-2 Genotypes to Decipher the Genetic Architecture of Bladder Cancer Risk
    CHENG-HSI LIAO, WEN-SHIN CHANG, SHU-YU CHANG, YUN-CHI WANG, JAW-CHYUN CHEN, HOU-YU SHIH, CHAO-HSIANG CHANG, WEN-CHI CHEN, DA-TIAN BAU and CHIA-WEN TSAI
    Anticancer Research April 2026, 46 (4) 1861-1874; DOI: https://doi.org/10.21873/anticanres.18079
  • Open Access
    The Glucose and Glutamine Requirements of Cancer and Normal Cells Do Not Distinguish Them, in Contrast to Their Methionine Requirement, Suggesting the Warburg Effect Is Not a Cancer Paradigm
    YUTA MIYASHI, KOHEI MIZUTA, TOMOYUKI ISHIGURO, QINGHONG HAN, SHUKUAN LI, BYUNG MO KANG, JIN SOO KIM, MICHAEL BOUVET, YASUNORI TOME, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Anticancer Research April 2026, 46 (4) 1875-1882; DOI: https://doi.org/10.21873/anticanres.18080
  • You have access
    Allow Aloe to Do the Work: Aloe vera Constrains Growth of Bladder Cancer Cells and Modulates Expression of Key Costimulatory Molecules
    ARTURO G. GUTIU, AUSTIN J. MARRAH, BRADY B. VOSS, BRAYDON C. COWAN, TRENTON G. MAYBERRY, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research April 2026, 46 (4) 1883-1892; DOI: https://doi.org/10.21873/anticanres.18081
  • You have access
    Chemosensitizing Effects of Resveratrol Derivatives on p53-dependent Apoptosis Triggered by Cisplatin in Human Lung Cancer Cells
    THANAWUT PRAMUALSIN, ZIN ZIN EI, SATAPAT RACHA, NICHARAT SRIRATANASAK, MASASHI YOKOYA, YUKIHA IIDA and PITHI CHANVORACHOTE
    Anticancer Research April 2026, 46 (4) 1893-1901; DOI: https://doi.org/10.21873/anticanres.18082
  • You have access
    VEGF and Hypoxia Independently Induce MDR1 Expression to Promote Endothelial Cell Angiogenesis
    HYEONG SIM CHOI, SUNG-GOOK CHO, MIN KYOUNG KIM, SEONG-GYU KO and PIL-YOUNG YUN
    Anticancer Research April 2026, 46 (4) 1903-1916; DOI: https://doi.org/10.21873/anticanres.18083
  • You have access
    PKF118-310 as a Potential Small Molecule Inhibitor Targeting the Wnt/β-Catenin Pathway for Gastric Cancer Therapy
    TE-SHENG CHANG, CHIN LI, WEI-MING CHEN, YUNG-YU HSIEH, KUO-LIANG WEI, CHUNG-KUANG LU and MING-KO CHIANG
    Anticancer Research April 2026, 46 (4) 1917-1927; DOI: https://doi.org/10.21873/anticanres.18084
  • You have access
    Paired-sample Analysis of ERG Expression and TMPRSS2–ERG Fusion in Treatment-induced Neuroendocrine Prostate Cancer
    RYUTA WATANABE, RYU SHIGEHISA, TATSUSHI KAWADA, SHINKURO YAMAMOTO, SATOSHI KATAYAMA, ATSUSHI TAKAMOTO, KENICHI NISHIMURA, NORIYOSHI MIURA, MOTOO ARAKI, KEIJI INOUE and TAKASHI SAIKA; on behalf of Chu-shikoku Japan Urological Consortium (CsJUC) Research Collaboration
    Anticancer Research April 2026, 46 (4) 1929-1942; DOI: https://doi.org/10.21873/anticanres.18085
  • You have access
    Tenofovir Alafenamide Promotes Differentiation and Induces Apoptosis of AML Cells by Inhibiting Telomerase Reverse Transcriptase
    JI-EUN LEE, BYEOL-EUN JEON, CHAN-SEONG KWON, SU-JI LEE, YOUNGSEOB SEO, HO-JIN SHIN and SANG-WOO KIM
    Anticancer Research April 2026, 46 (4) 1943-1955; DOI: https://doi.org/10.21873/anticanres.18086
  • You have access
    Methoxy and Ketone Substitutions of Resveratrol Enhance Its Anticancer Activity by Increasing MEK and ERK Binding Affinity in Colorectal Cancer Cells
    PATTHARAPORN SAELIM, ZIN ZIN EI, SATAPAT RACHA, MASASHI YOKOYA, RIKAKO YAMASHITA, PREEDAKORN CHUNHACHA and PITHI CHANVORACHOTE
    Anticancer Research April 2026, 46 (4) 1957-1966; DOI: https://doi.org/10.21873/anticanres.18087
  • You have access
    Integrative Analysis Combining Machine Learning and Functional Experiments Uncovers ISG15 As a Key Determinant of Cisplatin Resistance in Gastric Cancer
    WEIWEI WANG, HAIQUAN LING, SONGHAO HU, ZEHUAN CHEN, JUN ZHOU, AIWEN FENG, CUNCHUAN WANG and MINGHUI MA
    Anticancer Research April 2026, 46 (4) 1967-1992; DOI: https://doi.org/10.21873/anticanres.18088
  • You have access
    JI-CJ001 Enhances Paclitaxel Sensitivity in Gastric Cancer Cell Lines through Inhibition of HER2/mTOR Signaling and Induction of Autophagy
    MIN-WOO KIM, SANG-EUN LEE, SO EUN PARK, CHUNHOO CHEON and SEONG-GYU KO
    Anticancer Research April 2026, 46 (4) 1993-2006; DOI: https://doi.org/10.21873/anticanres.18089
  • You have access
    Phosphodiesterase 5 Inhibitor Sildenafil Inhibits HPV+ Cervical Cancer Cells and Cervical Cancer Stem Cells by Apoptotic Induction and Telomerase Activity Modulation
    SOLANKI SARKAR, AMRITA SAHA, BASABKANTI DAS, DEBAPRATIM DAS and ARUNIMA BISWAS
    Anticancer Research April 2026, 46 (4) 2007-2024; DOI: https://doi.org/10.21873/anticanres.18090

Clinical Studies

  • Open Access
    Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers
    SANT P. CHAWLA, SAMANTHA JEFFREY, SKYLER S. PANG, ROBIN L. JONES, STEFAAN W. VAN GOOL, TIMO HUBER, JENNIFER KOSMAL, NEAL S. CHAWLA, RHEANNA CARTER, CHARLES B. SIMONE, KAMBIZ NAEL, HOWARD BRUCKNER, ANNA GATTANI, PAUL Y. SONG, FREDERICK L. HALL and ERLINDA M. GORDON
    Anticancer Research April 2026, 46 (4) 2025-2034; DOI: https://doi.org/10.21873/anticanres.18091
  • Open Access
    Upfront Radiation Therapy Increases Severe Neurotoxicity Risk in Patients With Oligodendrogliomas
    ALEXIS DEMOPOULOS, JOHNATHAN KNISELY, MICHAEL SCHULDER, REEMA SHAH-DEMOPOULOS, JULIA GOMEZ and JIAN YI LI
    Anticancer Research April 2026, 46 (4) 2035-2043; DOI: https://doi.org/10.21873/anticanres.18092
  • Open Access
    Survival Then and Now in Patients With Surgically Resected Brain Metastasis: Major Improvement in Cases With Controlled Primary Tumor
    CARSTEN NIEDER, ELLINOR C. HAUKLAND, BENCE FAJTH and BÅRD MANNSÅKER
    Anticancer Research April 2026, 46 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.18093
  • Open Access
    Balloon-occluded Infusion of Fragmented Gelatin Particles of Transarterial Embolization for Hypervascular Hepatic Metastases: A Prospective Trial
    SODAI HOSHIAI, TAKESHI YAMADA, MARIKO KOBAYASHI, TAISHI AMANO, NOBUYUKI TAKAHASHI, BRYAN J. MATHIS, TSUKASA SAIDA, TAKAHITO NAKAJIMA and TOSHIYUKI IRIE
    Anticancer Research April 2026, 46 (4) 2053-2062; DOI: https://doi.org/10.21873/anticanres.18094
  • You have access
    Impact of Postoperative Prognostic Nutritional Index on Post-gastrectomy Outcomes in Older Adults With Gastric Cancer
    KOZO MIYATANI, TOMOYUKI MATSUNAGA, HIROAKI SAITO, TOMOHIRO OSAKI, SADAMU TAKAHASHI, AKEMI IWAMOTO, TOSHIO YAMAMOTO, KENJI FUKUDA, KENJIRO TANIGUCHI, HIROHIKO KURODA and YOSHIYUKI FUJIWARA
    Anticancer Research April 2026, 46 (4) 2063-2076; DOI: https://doi.org/10.21873/anticanres.18095
  • Open Access
    Clinicopathological Characteristics and Clinical Course of Non-muscle-invasive Bladder Cancer Secondary to Radical Nephroureterectomy
    TAKUMA SATO, TAKESHI SANO, HISANOBU ADACHI, YOSHIHIRO IKEDA, JUN TAKEMOTO, SHINGO MYOEN, KOJI MITSUZUKA, ATSUSHI KYAN, HIROSHI AOKI, SATORU TOKUYAMA, HIDEO SAITO, SHINICHI YAMASHITA, YOICHI ARAI, TAKASHI KOBAYASHI and AKIHIRO ITO
    Anticancer Research April 2026, 46 (4) 2077-2086; DOI: https://doi.org/10.21873/anticanres.18096
  • You have access
    Relationship Between Histopathological Growth Patterns and Indocyanine Green Fluorescence in Colorectal Liver Metastases
    RYO KATAYAMA, TAKESHI AOKI, YOSHIHIKO TASHIRO, TAKAHITO HIRAI, KEN NAITO, KAZUHIRO MATSUDA, AKIRA FUJIMORI, TOMOKAZU KUSANO, KOJI NOGAKI, HIDEKI SHIBATA, KODAI TOMIOKA, MARIE UCHIDA, KAZUHIKO SAITO, TATSUYA YAMAZAKI, SHODAI NAGAISHI, YUKARI SHINOHARA and YUTA ENAMI
    Anticancer Research April 2026, 46 (4) 2087-2093; DOI: https://doi.org/10.21873/anticanres.18097
  • You have access
    Adverse Events and Safety Outcomes Associated With Chemotherapy for Inflammatory Bowel Disease–associated Gastrointestinal Cancers
    NOBORU HASEGAWA, TAKAYUKI OGINO, YUKI SEKIDO, MITSUNOBU TAKEDA, TSUYOSHI HATA, ATSUSHI HAMABE, NORIKATSU MIYOSHI, MAMORU UEMURA, HIDETOSHI EGUCHI and YUICHIRO DOKI
    Anticancer Research April 2026, 46 (4) 2095-2104; DOI: https://doi.org/10.21873/anticanres.18098
  • You have access
    Impact of Biopsy Diagnostic Methods on the Prognosis of Stage I Endometrioid Cancer
    LUCAS HELMS, LAURA SABIANI, SARA DJEMOUAI, CAROLINE RAMBEAUD, PATRICE CROCHET, ANTOINE NETTER, XAVIER CARCOPINO and AUBERT AGOSTINI
    Anticancer Research April 2026, 46 (4) 2105-2114; DOI: https://doi.org/10.21873/anticanres.18099
  • You have access
    Feasibility of Elastography for Preoperative Prediction of Malignancy of Gastrointestinal Stromal Tumor of the Stomach
    MOTOHIRA YOSHIDA, TARO OSHIKIRI, SATOSHI KIKUCHI, SATOSHI AKITA, HIROKI SUGISHITA, HIRONORI MATSUMOTO, YUSUKE OGI, TAKAYUKI ANAI, TATSUHIKO KUME, KENJI TAKAGI, KATSUYA WATANABE, TAKAYASU KAWAMOTO, JUN KUWABARA, RYUTA MASUYA, SHIGEHIRO KOGA and KEI ISHIMARU
    Anticancer Research April 2026, 46 (4) 2115-2124; DOI: https://doi.org/10.21873/anticanres.18100
  • You have access
    The Role of MRI in the Preoperative Staging of Rectal Cancer: Ten-year Experience from a Single Tertiary Center
    ARIELLA EDINA KONDOR, ANDRÁS VERECZKEI, PÉTER VARGA, LILI DÓRA SINDLER, YASHWANTH SUDHEENDRA GOWDA, TÍMEA DERGEZ, ELISABETH GARCIA, ARMAND CSONTOS, NÁNDOR FALUHELYI, IVETT HEGEDŰS, BARNA BOGNER and JÓZSEF BARACS
    Anticancer Research April 2026, 46 (4) 2125-2132; DOI: https://doi.org/10.21873/anticanres.18101
  • You have access
    Clinical Outcomes of the Optimized Weekly 8-Gy Palliative Radiotherapy Regimen
    TAKESHI FUJISAWA, KENJI MAKITA, MASAKI NAKAMURA, HIDENARI HIRATA, HIDEHIRO HOJO, KEITA TSUKAHARA, HIDEKAZU OYOSHI, YUZHENG ZHOU and SADAMOTO ZENDA
    Anticancer Research April 2026, 46 (4) 2133-2144; DOI: https://doi.org/10.21873/anticanres.18102
  • You have access
    Real-world Comparative Study of Androgen Receptor Signaling Inhibitors in Japanese Patients With Non-metastatic Castration-resistant Prostate Cancer
    MASAAKI YANISHI, SEIJI SHIMADA, TAKAO MISHIMA and HIDEFUMI KINOSHITA
    Anticancer Research April 2026, 46 (4) 2145-2151; DOI: https://doi.org/10.21873/anticanres.18103
  • You have access
    Impact of Reconstruction Type and Pancreatic Atrophy on Glycemic Variability After Distal Gastrectomy
    KEIJI NISHIBEPPU, TAKESHI KUBOTA, HIROYUKI INOUE, KAZUYA TAKABATAKE, TOSHIYUKI KOSUGA, HIROTAKA KONISHI, HITOSHI FUJIWARA, KENTO KURASHIMA, HIDEMASA KUBO, JUN KIUCHI, TAISUKE IMAMURA, KENJI NANISHI, HIROKI SHIMIZU, TOMOHIRO ARITA, YUSUKE YAMAMOTO, RYO MORIMURA and ATSUSHI SHIOZAKI
    Anticancer Research April 2026, 46 (4) 2153-2162; DOI: https://doi.org/10.21873/anticanres.18104
  • You have access
    Postoperative Bleeding After Gastrectomy for Gastric Cancer in Patients Receiving Antiplatelet and/or Anticoagulation Treatment
    TORU AOYAMA, HARUHIKO CHO, HIDEAKI SUEMATSU, KENTARO HARA and AYA SAITO
    Anticancer Research April 2026, 46 (4) 2163-2173; DOI: https://doi.org/10.21873/anticanres.18105
  • You have access
    Clinical Outcomes of Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract
    YUZHENG ZHOU, MASAKI NAKAMURA, KENJI MAKITA, YUICHI HIROSHIMA, HIDENARI HIRATA, TOSHIYA RACHI, HIROMI BABA, MASASHI WAKABAYASHI, MASAFUMI IKEDA, NAOTO GOTOHDA and SADAMOTO ZENDA
    Anticancer Research April 2026, 46 (4) 2175-2185; DOI: https://doi.org/10.21873/anticanres.18106
  • You have access
    Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab
    YOSUKE SUGIYAMA, TAKU NAIKI, TOSHIHARU MORIKAWA, KUNIHIRO ODAGIRI, YOSHIHISA MIMURA, YOSHIHIKO TASAKI, NOBUHIKO SHIMIZU, TAKASHI NAGAI, TOSHIKI ETANI, DAIKI ISHIKAWA, MISATO TOMITA, MOEKO IIDA, NANAMI ITO, YUKA KIMURA, YUJI HOTTA, TAKAHIRO YASUI and YOKO FURUKAWA-HIBI
    Anticancer Research April 2026, 46 (4) 2187-2198; DOI: https://doi.org/10.21873/anticanres.18107
  • You have access
    Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer
    CHUNG RYUL OH, JAE HYUK DO, HYOUNG-CHUL OH, YOO SHIN CHOI, SEUNG EUN LEE, SOON AUCK HONG, MINEUI HONG and IN GYU HWANG
    Anticancer Research April 2026, 46 (4) 2199-2209; DOI: https://doi.org/10.21873/anticanres.18108
  • You have access
    Delayed Initiation of Postoperative S-1 Adjuvant Chemotherapy Worsens Prognosis After Gastric Cancer Recurrence
    KEIJI NISHIBEPPU, SHINICHI SAKURAMOTO, YOSUKE MORIMOTO, KAZUAKI MATSUI, GEN EBARA, SHOHEI FUJITA, SHIRO FUJIHATA, SHUICHIRO OYA, SEIGI LEE, YUTAKA MIYAWAKI, HIROFUMI SUGITA, HIROSHI SATO, KEISHI YAMASHITA and ATSUSHI SHIOZAKI
    Anticancer Research April 2026, 46 (4) 2211-2221; DOI: https://doi.org/10.21873/anticanres.18109
  • You have access
    Comparison of D2 and Non-D2 Lymphadenectomy in Older Patients (≥75 years) Undergoing Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Multicenter Retrospective Propensity Score-matched Analysis
    YUMA EBIHARA, NORIAKI KYOGOKU, HIRONOBU TAKANO, HIDEYUKI WADA, TAKEO NITTA, DAISUKE SAIKAWA, YOSHIYUKI YAMAMURA, MINORU TAKADA, TOSHIAKI SHICHINOHE and SATOSHI HIRANO
    Anticancer Research April 2026, 46 (4) 2223-2237; DOI: https://doi.org/10.21873/anticanres.18110
  • You have access
    Prognostic Impact of Lymph Node Ratio in Patients With Gastric Cancer Undergoing Curative Gastrectomy Post Neoadjuvant Chemotherapy
    KEISUKE KOMORI, NORIHIRO AKIMOTO, YUTA NAKAYAMA, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TAKANOBU YAMADA, TAKASHI OGATA, AYA SAITO and TAKASHI OSHIMA
    Anticancer Research April 2026, 46 (4) 2239-2247; DOI: https://doi.org/10.21873/anticanres.18111
  • You have access
    Efficacy of Aprepitant for Nausea and Vomiting Induced by CHOP/R-CHOP or Pola-R-CHP Chemotherapy
    TAKANORI MIYOSHI, ERIKO KASHIWAGI, HINAKO KOIZUMI, YOKO FUJISE, KUNIO OOHASHI, KEN TAKASE and MASASHI HASHIMOTO
    Anticancer Research April 2026, 46 (4) 2249-2257; DOI: https://doi.org/10.21873/anticanres.18112
  • You have access
    Post-progression Nutritional and Immune Status Determines Survival After First-line Chemotherapy in Unresectable Advanced Gastric Cancer
    NORIHIRO AKIMOTO, YUTA NAKAYAMA, KEISUKE KOMORI, ITARU HASHIMOTO, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TAKANOBU YAMADA, TAKASHI OGATA, SHUNTARO ISHIKAWA, MISA ONISHI, TAKANORI HAMA, HIROSHI NAKANOMA, MITSUHIRO HURUTA, HIROKI OSUMI, NORIO YUKAWA, AYA SAITO and TAKASHI OSHIMA
    Anticancer Research April 2026, 46 (4) 2259-2265; DOI: https://doi.org/10.21873/anticanres.18113
  • You have access
    Factors Associated With Nonadherence to S-1 in Docetaxel+S-1(DS) Therapy, an Adjuvant Treatment for Gastric Cancer
    YUKA KIMURA, KAZUYOSHI KAWAKAMI, MASASHI NAKAMURA, TAKASHI YOKOKAWA, KAZUO KOBAYASHI, TAKESHI AOYAMA, WATARU SUZUKI, HISANORI SHIMIZU, MASAHIRO HATORI, MAKOTO HIRAIDE, KENICHI SUZUKI, DAISUKE TAKAHARI, KENSEI YAMAGUCHI and MASAKAZU YAMAGUCHI
    Anticancer Research April 2026, 46 (4) 2267-2275; DOI: https://doi.org/10.21873/anticanres.18114
  • You have access
    Whole-liver Palliative Radiotherapy Using SIB for Diffuse Liver Metastases: 3D-CRT versus 99mTc-GSA SPECT Image-guided VMAT
    YOSHINOBU SHIMOHIGASHI, RYO TOYA, YUDAI KAI, YASUHIRO DOI, SHINYA SHIRAISHI, MASATO MARUYAMA, YOSHIFUMI MATSUSHIMA, JUN NAKAGAWA, TAKAAKI NAKAMURA, TOSHINORI HIRAI and NATSUO OYA
    Anticancer Research April 2026, 46 (4) 2277-2284; DOI: https://doi.org/10.21873/anticanres.18115

Case Reports

  • You have access
    Transoral Robotic Surgery for High Grade Oropharyngeal Mucoepidermoid Carcinoma With Good Outcome and Preserved Oropharyngeal Functions
    AUSTIN M. YU, THOMAS R. O’TOOLE and JINPING LAI
    Anticancer Research April 2026, 46 (4) 2285-2289; DOI: https://doi.org/10.21873/anticanres.18116
  • You have access
    Usefulness of Artificial Intelligence for Surgical Support in Robot-assisted Distal Pancreatectomy: A Preliminary Case Report
    KAZUHIRO MATSUDA, TAKESHI AOKI, NAO KOBAYASHI, YOSHIHIKO TASHIRO, KODAI TOMIOKA, TOMOKAZU KUSANO, HIDEKI SHIBATA, KOJI NOGAKI, SHODAI NAGAISHI, KAZUHIKO SAITO, TATSUYA YAMAZAKI, AKIRA FUJIMORI, HIROMI DATE, RYOHEI WATANABE, KIMIYASU YAMAZAKI, MAKOTO WATANABE, YUTA ENAMI and HIROKI YAMAUE
    Anticancer Research April 2026, 46 (4) 2291-2296; DOI: https://doi.org/10.21873/anticanres.18117
Back to top
Previous

In this issue

Anticancer Research: 46 (4)
Anticancer Research
Vol. 46, Issue 4
April 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)

Issue highlights

  • Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers
  • Upfront Radiation Therapy Increases Severe Neurotoxicity Risk in Patients With Oligodendrogliomas
  • P53-armed Oncolytic Adenovirus Enhances the Efficacy of PD-1 Blockade in Neuroblastoma by Inducing Immunogenic Cell Death
  • Advanced Reliability of Radiomic Features in Ex Vivo HypersightTM-CBCT Imaging by iCBCT-Acuros Reconstruction
  • Establishment of Gemcitabine-resistant Mouse Pancreatic Ductal Adenocarcinoma Cell Line and Possible Therapeutic Agents
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Case Reports
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire